Photo of Alexander Sandberg

Alexander Sandberg

Principal Research Engineer

Publications

2026

Yura Seo, Yoon Dae Han, Linda Bojmar, Kyung-A Kim, Yurin Seo, Taeyul K. Kim, Suho Lee, Yeleem Kim, Hye Bin Choi, Yujin H. Lim, Chae Hyun Kim, Alexander Sandberg, Chuanwen Fan, Pernille Lauritzen, Henrik Molina, Christopher Peralta, Jacob B. Geri, Colin Burdette, Dai Hoon Han, Heon Yung Gee, Insuk Lee, Jeon-Soo Shin, Hyunwook Kim, Leon Li, Gabriel C. Tobias, Inbal Wortzel, Sang Joon Shin, Hyo-Il Jung, Min Goo Lee, Soonmyung Paik, Robert E. Schwartz, Joong Bae Ahn, David Lyden, Han Sang Kim (2026) Proteomic Profiling of Human Extracellular Vesicles Reveals Diagnostic Biomarkers for Colon Adenocarcinoma Journal of Extracellular Vesicles, Vol. 15, Article e70278 (Article in journal) Continue to DOI

2024

Lovisa Johansson, Alexander Sandberg, Sofie Nyström, Per Hammarström, Martin Hallbeck (2024) Amyloid beta 1-40 and 1-42 fibril ratios and maturation level cause conformational differences with minimal impact on autophagy and cytotoxicity Journal of Neurochemistry, Vol. 168, p. 3308-3322 (Article in journal) Continue to DOI

2020

Alexander Sandberg, Helen Ling, Marla Gearing, Beth Dombroski, Laura Cantwell, Lea RBibo, Allan Levey, Gerard D. Schellenberg, John Hardy, Nicholas Wood, Josefin Fernius, Sofie Nyström, Samuel Svensson, Stefan Thor, Per Hammarström, Tamas Revesz, Kin Y. Mok (2020) Fibrillation and molecular characteristics are coherent with clinical and pathological features of 4-repeat tauopathy caused by MAPT variant G273R Neurobiology of Disease, Vol. 146, Article 105079 (Article in journal) Continue to DOI

2019

Alexander Sandberg (2019) Polymorphic protein aggregation in tauopathies
Maria Jonson, Sofie Nyström, Alexander Sandberg, Marcus Carlback, Wojciech Michno, Jorg Hanrieder, Annika Starkenberg, K. Peter, Peter Nilsson, Stefan Thor, Per Hammarström (2019) Amyloid fibril polymorphism and cell-specific toxicity in vivo Amyloid: Journal of Protein Folding Disorders, Vol. 26, p. 136-137 (Article in journal) Continue to DOI